Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Zonagen, Incorporated (NasdaqNM:ZONA)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials
Location
2408 Timberloch Place, Suite B-4
The Woodlands, TX 77380
Phone: (281) 367-5892
Fax: (281) 363-8796
Employees (last reported count): 11
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 13%
·Institutional: 17% (19% of float)
(33 institutions)
·Net Inst. Buying: 68.0K shares (+3.50%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Zonagen, Incorporated is a development stage biopharmaceutical company engaged in the development of products for the reproductive system, including sexual dysfunction, vaccine adjuvants, products for fertility and female health, as well as urological applications, specifically prostate cancer. Zonagen's lead product, Vasomax, is a rapidly disintegrating oral formulation of phentolamine for the treatment of male erectile dysfunction (MED). Vasofem is being developed by the Company to treat female sexual dysfunction. Zonagen is developing a new class of compounds, the initial focus of which will be endometriosis and uterine fibroids. The Company is developing two therapeutic vaccine products to prevent contraception by stimulating an immune response.
More from Market Guide: Expanded Business Description

Financial Summary
Zonagen, Inc. is development stage biopharmaceutical company engaged in the development of pharmaceutical products for the reproductive system, including sexual dysfunction, urology, contraception and infertility. For the six months ended 6/30/01, total revenues fell 3% to $2.1 million. Net loss before acct. change fell 87% to $254 thousand. Results reflect increased revenue from SBIR grants and lower R&D expenses due to a cost reduction program.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
Martin P. Sutter, Chmn.
Joseph S. Podolski, Pres./CEO
Paul Lammers, Sr. VP.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:ZONAAs of 31-Aug-2001
Price and Volume
52-Week Low
on 4-Dec-2000
$1.625
Recent Price$4.03 
52-Week High
on 1-Sep-2000
$5.00 
Beta1.63 
Daily Volume (3-month avg)21.3K
Daily Volume (10-day avg)47.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y]
52-Week Change-9.8%
52-Week Change
relative to S&P500
+21.0%
Share-Related Items
Market Capitalization$45.7M
Shares Outstanding11.3M
Float9.90M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$2.73 
Earnings (ttm)-$0.10 
Earnings (mrq)-$0.01 
Sales (ttm)$0.40 
Cash (mrq)$2.07 
Valuation Ratios
Price/Book (mrq)1.48 
Price/EarningsN/A 
Price/Sales (ttm)10.09 
Income Statements
Sales (ttm)$4.52M
EBITDA (ttm)-$758.0K
Income available to common (ttm)-$1.07M
Profitability
Profit Margin (ttm)-23.7%
Operating Margin (ttm)-23.7%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-2.64%
Return on Equity (ttm)-3.15%
Financial Strength
Current Ratio (mrq)6.08 
Debt/Equity (mrq)0 
Total Cash (mrq)$23.5M
Short Interest
As of 8-Aug-2001
Shares Short1.09M
Percent of Float11.0%
Shares Short
(Prior Month)
1.09M
Short Ratio51.95 
Daily Volume21.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.